OasisLMS

Co-clinical Models to Interrogate Neo[Pro]plasia Models - Chair
Presenter: Sunita Agarwal, PhD (NIDDK/NIH)
No relevant financial relationships

Co-clinical Models to Interrogate Neo[Pro]plasia Models - Chair
Presenter: Kate Lines, PhD (University of Oxford)
Relationship: Commercial Interest(s)
  Advisory Board Member: Recordati, HRA Pharma, Strongbridge, Ipsen, Chiasma.
  Grant Recipient: Chiasma, Recordati - institutional-directed grant for multicentric trial, Strongbridge - institutional-directed grant for multicentric trial.

Co-clinical Models to Interrogate Neo[Pro]plasia Models - Notch-1 Signaling pathway in NETs: From Pathway Analysis to Personalized Medicine
Presenter: Herbert Chen, MD (University of Alabama at Birmingham)
No relevant financial relationships

Co-clinical Models to Interrogate Neo[Pro]plasia Models - The Role of Subcellular Localization of FAK in Thyroid Cancer
Presenter: Rebecca Schweppe, PhD (University of Colorado School of Medicine)
Relationship: Commercial Interest(s)
  Advisory Board Member: Recordati, HRA Pharma, Strongbridge, Ipsen, Chiasma.
  Grant Recipient: Chiasma, Recordati - institutional-directed grant for multicentric trial, Strongbridge - institutional-directed grant for multicentric trial.

Co-clinical Models to Interrogate Neo[Pro]plasia Models - Novel Therapies Targeting the RABL6A-RB1 Axis for Neuroendocrine Tumors
Presenter: Dawn Quelle, PhD (University of Iowa)
No relevant financial relationships